Cargando…
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer
Anticoagulation is used to treat venous thromboembolism (VTE) in cancer patients, but may be associated with an increased risk of bleeding. VTE recurrence and major bleeding were assessed in cancer patients treated for VTE with the most currently prescribed anticoagulants in clinical practice. Newly...
Autores principales: | Streiff, Michael B., Milentijevic, Dejan, McCrae, Keith, Yannicelli, Daniel, Fortier, Jonathan, Nelson, Winnie W., Laliberté, François, Crivera, Concetta, Lefebvre, Patrick, Schein, Jeff, Khorana, Alok A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947542/ https://www.ncbi.nlm.nih.gov/pubmed/29396864 http://dx.doi.org/10.1002/ajh.25059 |
Ejemplares similares
-
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis
por: Khorana, Alok A., et al.
Publicado: (2017) -
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019) -
The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018) -
Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017) -
Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels
por: Khorana, Alok A., et al.
Publicado: (2020)